Eric W. J. Gates

Structure-activity relationships of N-terminal variants of peptidomimetic tissue transglutaminase inhibitors.

R. Eckert, J. Tyndall, N. Firoozi, 2022, European journal of medicinal chemistry.

Sulforaphane covalently interacts with the transglutaminase 2 cancer maintenance protein to alter its structure and suppress its activity

David J Weber, J. Lakowicz, H. Szmacinski, 2021, Molecular carcinogenesis.

A Multidisciplinary Approach Establishes a Link between Transglutaminase 2 and the Kv10.1 Voltage-Dependent K+ Channel in Breast Cancer

S. Volinia, V. Bertagnolo, Silvia Grassilli, 2022, Cancers.

Peptidic Inhibitors and a Fluorescent Probe for the Selective Inhibition and Labelling of Factor XIIIa Transglutaminase

M. Kaartinen, J. Keillor, Eric W. J. Gates, 2023, Molecules.